TY - JOUR
T1 - Interventions to improve delivery of cancer genetics services in the United States
T2 - A scoping review
AU - Bednar, Erica M.
AU - Nitecki, Roni
AU - Krause, Kate J.
AU - Rauh-Hain, Jose Alejandro
N1 - Funding Information:
The work is supported by The University of Texas MD Anderson Cancer Center Moon Shot Program (E.M.B.) and by grants from the National Institutes of Health National Cancer Institute (J.A.R.-H.: K08 CA234333; E.M.B., R.N., K.J.K., and J.A.R.-H.: P30 CA016672; R.N.: 5T32 CA101642). The funding sources were not involved in the development of the research hypothesis, study design, data analysis, or manuscript writing. Editorial support was provided by Bryan Tutt, Scientific Editor, Research Medical Library.
Publisher Copyright:
© 2022 American College of Medical Genetics and Genomics
PY - 2022/6
Y1 - 2022/6
N2 - Purpose: Interventions that decrease barriers and improve clinical processes can increase patient access to guideline-recommended cancer genetics services. We sought to identify and describe interventions to improve patient receipt of guideline-recommended cancer genetics services in the United States. Methods: We performed a comprehensive search in Ovid MEDLINE and Embase, Scopus, and Web of Science from January 1, 2000 to February 12, 2020. Eligible articles reported interventions to improve the identification, referral, genetic counseling (GC), and genetic testing (GT) of patients in the United States. We independently screened titles and abstracts and reviewed full-text articles. Data were synthesized by grouping articles by clinical process. Results: Of 44 included articles, 17 targeted identification of eligible patients, 14 targeted referral, 15 targeted GC, and 16 targeted GT. Patient identification interventions included universal tumor testing and screening of medical/family history. Referral interventions included medical record system adaptations, standardizing processes, and provider notifications. GC interventions included supplemental patient education, integrated GC within oncology clinics, appointment coordination, and alternative service delivery models. One article directly targeted the GT process by implementing provider-coordinated testing. Conclusion: This scoping review identified and described interventions to improve US patients’ access to and receipt of guideline-recommended cancer genetics services.
AB - Purpose: Interventions that decrease barriers and improve clinical processes can increase patient access to guideline-recommended cancer genetics services. We sought to identify and describe interventions to improve patient receipt of guideline-recommended cancer genetics services in the United States. Methods: We performed a comprehensive search in Ovid MEDLINE and Embase, Scopus, and Web of Science from January 1, 2000 to February 12, 2020. Eligible articles reported interventions to improve the identification, referral, genetic counseling (GC), and genetic testing (GT) of patients in the United States. We independently screened titles and abstracts and reviewed full-text articles. Data were synthesized by grouping articles by clinical process. Results: Of 44 included articles, 17 targeted identification of eligible patients, 14 targeted referral, 15 targeted GC, and 16 targeted GT. Patient identification interventions included universal tumor testing and screening of medical/family history. Referral interventions included medical record system adaptations, standardizing processes, and provider notifications. GC interventions included supplemental patient education, integrated GC within oncology clinics, appointment coordination, and alternative service delivery models. One article directly targeted the GT process by implementing provider-coordinated testing. Conclusion: This scoping review identified and described interventions to improve US patients’ access to and receipt of guideline-recommended cancer genetics services.
KW - Cancer genetics
KW - Genetic counseling
KW - Genetic testing
KW - Interventions
KW - Scoping review
UR - http://www.scopus.com/inward/record.url?scp=85127807260&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127807260&partnerID=8YFLogxK
U2 - 10.1016/j.gim.2022.03.002
DO - 10.1016/j.gim.2022.03.002
M3 - Review article
C2 - 35389342
AN - SCOPUS:85127807260
SN - 1098-3600
VL - 24
SP - 1176
EP - 1186
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 6
ER -